BNB Plus (BNBX)
NASDAQ:BNBX
Want to see BNBX full AI Analyst Report?
BNBX Stock Chart & Stats
$1.48
--
Market closed
$1.48
--
Day’s Range― - ―
52-Week Range$0.35 - $7.15
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.96M
Market Cap
$3.35M
Enterprise Value-$393.81K
Total Cash (Recent Filing)$949.09K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.39
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-39.93
Shares Outstanding7,197,228
10 Day Avg. Volume46,292
30 Day Avg. Volume1,955,224
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.87
Price to Sales (P/S)0.94
P/FCF Ratio-0.16
Enterprise Value/Market Cap-0.12
Enterprise Value/Revenue-0.19
Enterprise Value/Gross Profit-0.43
Enterprise Value/Ebitda0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-82.5
Revenue Forecast (FY)$7.40M
Bulls Say, Bears Say
Bulls Say
Low Leverage / Stronger CapitalizationMinimal debt and a sharp increase in equity materially reduce financial risk and preserve strategic optionality. With low leverage the company has greater flexibility to pursue asset monetization, financing alternatives, or restructurings without immediate creditor constraints, lengthening runway for operational fixes.
TTM Revenue ReboundA near-term strong revenue rebound establishes a higher top-line base that can enable operating leverage if management controls costs. Sustained revenue gains improve scaling prospects, support potential margin recovery over months, and create clearer paths for monetizing business units like LineaRx.
Committed Preferred Financing Up To $5MA structured preferred-stock financing provides senior capital, liquidation preference and dividend terms that bolster liquidity and extend runway. It funds a strategic review and digital-asset treasury support, improving capacity to pursue monetization or strategic pivots without immediate cash-pressure-driven fire sales.
Bears Say
Large Negative Free Cash FlowPersistent negative operating and free cash flow indicates the business is consuming material cash relative to resources, forcing dependency on external financing. Over months this constrains R&D, commercialization, and strategic investment, raises dilution risk and places pressure on management to secure funding.
Severe Operating Losses And Weak MarginsExtremely negative operating and net margins show the current cost base is structurally misaligned with revenue. Such deep losses erode equity and limit the company's ability to self-fund growth; durable profitability will require either material cost reduction or a meaningful shift toward higher-margin revenue streams.
Nasdaq Listing Risk (bid-price Breach)A formal Nasdaq deficiency notice creates a structural liquidity and access-to-capital risk that can persist for months. Potential delisting would reduce investor base and fundraising options; related board authorizations (reverse split) are tactical fixes but do not address core profitability or cash-flow weaknesses.
BNB Plus News
BNBX FAQ
What was BNB Plus’s price range in the past 12 months?
BNB Plus lowest stock price was $0.35 and its highest was $7.15 in the past 12 months.
What is BNB Plus’s market cap?
BNB Plus’s market cap is $3.35M.
When is BNB Plus’s upcoming earnings report date?
BNB Plus’s upcoming earnings report date is Aug 06, 2026 which is in 54 days.
How were BNB Plus’s earnings last quarter?
BNB Plus released its earnings results on May 07, 2026. The company reported -$0.685 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.685.
Is BNB Plus overvalued?
According to Wall Street analysts BNB Plus’s price is currently Overvalued.
Does BNB Plus pay dividends?
BNB Plus does not currently pay dividends.
What is BNB Plus’s EPS estimate?
BNB Plus’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BNB Plus have?
BNB Plus has 7,197,228 shares outstanding.
What happened to BNB Plus’s price movement after its last earnings report?
BNB Plus reported an EPS of -$0.685 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.99%.
Which hedge fund is a major shareholder of BNB Plus?
Currently, no hedge funds are holding shares in BNBX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BNB Plus
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Technical Analysis
ENDRA Life Sciences
―
Intelligent Bio Solutions
―
iSpecimen
―
BioNexus Gene Lab Corp
―
―
Ownership Overview
2.34% Insiders
0.42% Mutual Funds
5.89% Other Institutional Investors
91.34% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---